SlideShare uma empresa Scribd logo
1 de 51
Sulfonylureas in Type II DM Too Many Options,  Too Little Clarity Dr. B. K. Iyer
Diabetes – Status Today Diabetes Reaching Epidemic proportion Monitoring difficulties/complications Economic Implications Prevalence of CAD in the diabetic population, i.e., major abnormalities in ECG, angina, or myocardial infarction (MI) is 2­4 times than observed in nondiabetics. Prevalence of CCF to which CAD and hypertension contribute, is increased 3- to 4-fold. Uusitupa M, Siitonen O, Aro A, Pyörälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.  Diabetologia  28:22-27, 1985.
Diabetes – Roadmap of Today What we know What we may not know What we need to know What we need to do after knowing The different sulfonylureas and relative comparisons Effects of sulfonylureas on cardiac risk factors Aspects of using sulfonylureas in diabetic patients The right approach to the choice of sulfonylureas Today’s review
What Is Known?
Normal Glucose Regulation insulin Fats Muscle insulin pancreatic islet  cells Glucose absorbed from intestine GLUCOSE ABSORPTION GLUCOSE PRODUCTION PERIPHERAL  GLUCOSE UPTAKE INSULIN SECRETION
OHAs Glucose Regulation Sulfonylureas Meglitinides Thiazolidinediones Metformin Thiazolidinediones  -Glucosidase Inhibitors Metformin Thiazolidinediones GLUCOSE ABSORPTION GLUCOSE PRODUCTION PERIPHERAL  GLUCOSE UPTAKE INSULIN SECRETION
Second Generation sulfonylureas  – what is known? Yes No No Yes Active metabolites 24 10-24 24 16-24 Duration of action 400 -1000 2.4 1-2 Glimepiride 50 -100 1 10 Glipizide 30 4 80 Gliclazide 150 -400 3 5 Glyburide [Glibenclamide] Relative potency Plasma Peak Equiv. Dose [mg.] Sulfonylurea
OHAs & Their Impact
Sulfonylureas – Mechanism Of Action sulfonylureas bind to a subunit of the ß-cell ATP-activated K channel complex (termed the sulfonylurea receptor) This binding reduces the rate of outward flow [efflux] of K+ ions across cell membrane & leads to closure of the channel   Kruszynska Y, Olefsky JM.  J Invest Med. 1996; 44:413-428. This depolarizes the membrane and triggers opening of voltage-sensitive Ca++ channels, leading to rapid influx of Ca Increased intracellular Ca++ causes an alteration in the cytoskeleton,  This stimulates translocation of insulin-containing secretory granules to the plasma membrane and exocytotic release of insulin.
What May Be Unknown?
Sulfonylureas  – what may be Unknown? What   is ischaemic preconditioning of myocardium? What is its   significance ? Various studies have provided excellent evidence that in diabetic patients, Sulfonylureas   bind also to cardiovascular K ATP  channels in the myocardium, although less well   than to ß-cell K ATP  channels chronic   inhibition of the K ATP  channel in the beta cells of the pancreas with oral sulfonylureas abolishes   ischaemic preconditioning of myocardium.
Significance  – ischaemic preconditioning of the myocardium ,[object Object],[object Object],[object Object],[object Object],ATP-dependent potassium  (KATP)  channels in: [1] vascular smooth muscle cells;  and  [2] myocardial cells  have an important role in this process. How? A process by which transitory ischemia in the heart "conditions" the myocardium in a protective fashion, allowing greater tolerance of subsequent ischemia. significance What
Sulfonylureas  – what may be Unknown? ,[object Object],[object Object],[object Object],[object Object],[object Object]
Sulfonylureas  – what may be Unknown? inhibit the opening of the potassium channel and promote closure interfere with the myocardial adaptive response Sulfonylureas could potentially disrupt this protective mechanism of ischaemic preconditioning by their presence and interaction with cardiovascular KATP. This could: This abolishing or opposing phenomenon might contribute to the increased cardiovascular mortality in sulfonylurea-treated diabetic patients
Sulfonylureas – What Is Unknown? Despite their comparable actions on the pancreatic beta-cell KATP channel, all sulfonylureas are not similar   because they strongly differ in their ability to interfere with vascular or cardiac KATP channels A useful pharmacological approach would be to identify   -cell-specific sulfonylureas to avoid adverse effects: on the cardiac myocyte, as well as vasculature Why?  Thus, what must be done?
How Does This Finding Advance Our Knowledge? Initiating / Continuance of long term oral pharmacotherapy Effects on fasting / Postprandial hyperglycaemia concern for benefits beyond the obvious concern for weight gain and hypo-glycaemia Expectations from sulfonylureas Rational Choice of Oral Antihyperglycaemic Agents, By Subhankar Chowdhury, Nilanjan Sengupta- JIMA, Vol. 100, No. 2, February 2002.
What Needs to Be Known?
Diabetic Patients and Complications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Free Radicals in Biology and Medcine, J. R. Pffafly, Spring 2001.
Choosing the Right sulfonylurea ,[object Object],[object Object],[object Object],[object Object]
Criteria for An Ideal sulfonylurea ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Is there such a sulfonylurea? Yes! GLIMEPIRIDE
Glimepiride - Introduction ,[object Object],[object Object],[object Object],[object Object]
Glimepiride - Pharmacokinetics ,[object Object],[object Object],[object Object],[object Object]
Glimepiride – Side Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Glimepiride – Availability and Dosage ,[object Object],[object Object],Begin with 1 mg daily  Increase by 1 mg every 1-2 weeks Most patients controlled with a dose of 4 mg or less. Divide dose If higher doses are needed Individual Dose to be titrated based on blood glucose levels
Glimepiride - Summary of Benefits ,[object Object],Specific site  binding Action on both Insulin phases Extrapancreatic actions Activity duration & dosage convenience Good safety profile Benefits beyond the obvious
Glimepiride Impact on Phases of Insulin Secretion ,[object Object],[object Object],Glimepiride improves first-phase insulin secretion, which plays an important role in reducing postprandial hyperglycemia.  Pharmacotherapy, 2004;24(5):606-620).   Sulfonylurea treatment of type 2 diabetes mellitus: Focus on glimepiride by Mary T. Korytkowski
Glimepiride Impact on Phases of Insulin Secretion ,[object Object],Diabetes care,  Vol.25, No. 9, Sept, 2002, by Mary Korytkowski Second-phase insulin secretion corresponds both to the release of stored secretory granules and to the de novo synthesis of insulin.
Glimepiride -  Comparison With Glipizide ,[object Object],[object Object],[object Object],[object Object],Pharmacotherapy, 2004;24(5):606-620).   Sulfonylurea treatment of type 2 diabetes mellitus: Focus on glimepiride by Mary T. Korytkowski
Glimepiride-  Comparison with Glibenclamide ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Glimepiride-  Hypoglycaemia ,[object Object],[object Object],[object Object],[object Object],[object Object]
Glimepiride -  Study in Obese / Non-obese ,[object Object],[object Object],Ann Pharmacother. 2004 Jan;38(1):30-5, Glimepiride pharmacokinetics in obese versus non-obese diabetic patients by Shukla UA, Chi EM, Lehr KH.
Glimepiride and Weight Gain ,[object Object],[object Object],[object Object],[object Object]
Glimepiride and Weight Gain ,[object Object],[object Object],[object Object]
Glimepiride and The GUIDE Study ,[object Object],[object Object],GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 2004 Aug;34(8):535-42, Schernthaner G, et al, Rudolfstiftung Hospital, Vienna, Austria.
Glimepiride and The GUIDE Study ,[object Object],[object Object],[object Object],GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 2004 Aug;34(8):535-42, Schernthaner G, et al, Rudolfstiftung Hospital, Vienna, Austria.
Glimepiride Vs. Metformin - A Study ,[object Object],[object Object],Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin, Diabetes Nutr Metab. 2004 Jun;17(3):143-50 by Derosa G, Franzetti I, Gadaleta G, Ciccarelli L, Fogari R. Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuderosa@tin.it
Glimepiride Vs. Metformin - A Study ,[object Object],[object Object],[object Object],Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin, Diabetes Nutr Metab. 2004 Jun;17(3):143-50 by Derosa G, Franzetti I, Gadaleta G, Ciccarelli L, Fogari R. Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuderosa@tin.it
Glimepiride  –  Lower Insulin Secretion ,[object Object],[object Object],[object Object]
Glimepiride  –  Lower Insulin Secretion ,[object Object],[object Object],[object Object],Glimepiride Provides Surprising Improvements in Insulin Resistance by Charles D. Ponte American Pharmaceutical Association, Drug Infoline, March 2003, Vol. 4, No. 3
Glimepiride –  Effects on Insulin Resistance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Glimepiride Provides Surprising Improvements in Insulin Resistance  by Charles D. Ponte, American Pharmaceutical Association, Drug Infoline, March 2003, Vol. 4, No. 3
Glimepiride – Extra Pancreatic Effects ,[object Object],[object Object],[object Object],[object Object],The Effect of Glimepiride on Glycemic Control and Fasting Insulin Levels By TING-TING SEE1 at al, Journal of Food and Drug Analysis, Vol. 11, No. 1, 2003, Pages 1-3
Glimepiride – Extra Pancreatic Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],Diabetes Care, November,2002.
Glimepiride  – Extra Pancreatic Effects ,[object Object],[object Object],[object Object],[object Object],[object Object]
Glimepiride – Extra Pancreatic Effects ,[object Object],[object Object],Diabetes Care, 26:285-289, 2003.
Glimepiride – Adiponectin Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes - Observations Diabetes Care,  July, 2003  by Shoichiro Nagasaka
Glimepiride - Summary ,[object Object],[object Object],[object Object],[object Object],Clin Ther. 2003 Mar;25(3):799-816, Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience by Massi-Benedetti M, Dipartimento di Medicina Interna, Universita di Perugia, Perugia, Italy.
What Needs to Be Done After Knowing? What Are the Lessons?
The Future of Sulfonylureas:  What Are the Lessons? Lesser Chances  of weight gain /  hypoglycaemia Decreased Insulinaemia Improvement In FBS, PPBG & Glycosylated Hb Lesser  risks of atherosclerosis Increased Adiponectinaemia Extrapancreatic Effects Beta-Cell specific Preserves Myocardial preconditioning Action on both Phases of Insulin Secretion Rapid and Longer Duration Of Action
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References ,[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

A new easy dpp 4i
A new easy dpp 4iA new easy dpp 4i
A new easy dpp 4i
Dr. Lin
 

Mais procurados (20)

Vildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitusVildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitus
 
GLP-1 Agonist
GLP-1 AgonistGLP-1 Agonist
GLP-1 Agonist
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)
 
GLP-1 and Diabetes Mellitus
GLP-1 and Diabetes MellitusGLP-1 and Diabetes Mellitus
GLP-1 and Diabetes Mellitus
 
Metformin
MetforminMetformin
Metformin
 
Sitagliptin an oral anti-diabetic agent
Sitagliptin an oral anti-diabetic agentSitagliptin an oral anti-diabetic agent
Sitagliptin an oral anti-diabetic agent
 
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
 
Dapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitorDapagliflozin- a novel SGLT2 inhibitor
Dapagliflozin- a novel SGLT2 inhibitor
 
Telmisartan
TelmisartanTelmisartan
Telmisartan
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugs
 
glyxambi
glyxambiglyxambi
glyxambi
 
Gliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes MellitusGliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes Mellitus
 
Beta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseasesBeta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseases
 
Linagliptin
LinagliptinLinagliptin
Linagliptin
 
Oral hypoglycaemic drugs
Oral hypoglycaemic drugsOral hypoglycaemic drugs
Oral hypoglycaemic drugs
 
Oral anti diabetic drugs
Oral anti diabetic drugs Oral anti diabetic drugs
Oral anti diabetic drugs
 
Angiotensin receptor blockers
Angiotensin receptor blockersAngiotensin receptor blockers
Angiotensin receptor blockers
 
Pioglitazone
PioglitazonePioglitazone
Pioglitazone
 
Sodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitorsSodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitors
 
A new easy dpp 4i
A new easy dpp 4iA new easy dpp 4i
A new easy dpp 4i
 

Destaque (7)

Insulin Resistance
Insulin ResistanceInsulin Resistance
Insulin Resistance
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
 
Acute and chronic complications of DM
Acute and chronic  complications  of DMAcute and chronic  complications  of DM
Acute and chronic complications of DM
 
Newer insulins in clinical practice
Newer insulins in clinical practiceNewer insulins in clinical practice
Newer insulins in clinical practice
 
Dental management of a diabetic patient
Dental  management of a diabetic patientDental  management of a diabetic patient
Dental management of a diabetic patient
 
Insulin analogues ppt
Insulin analogues pptInsulin analogues ppt
Insulin analogues ppt
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
 

Semelhante a Glimepiride

A practice to diabetes guidelines
A practice to diabetes guidelinesA practice to diabetes guidelines
A practice to diabetes guidelines
Walid Babikr
 
Diabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmedDiabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmed
aaiman46
 
diabetes mellitus.pptx
diabetes mellitus.pptxdiabetes mellitus.pptx
diabetes mellitus.pptx
DrAakankshaSharma1
 
Diabetes and Glucose Metabolism
Diabetes and Glucose MetabolismDiabetes and Glucose Metabolism
Diabetes and Glucose Metabolism
Patrick Carter
 
Diabetes Mellitus patients in dental management
Diabetes Mellitus patients in dental managementDiabetes Mellitus patients in dental management
Diabetes Mellitus patients in dental management
MedicineAndFamily
 

Semelhante a Glimepiride (20)

Dilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKDDilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKD
 
FORA_Patient_Brochure
FORA_Patient_BrochureFORA_Patient_Brochure
FORA_Patient_Brochure
 
A practice to diabetes guidelines
A practice to diabetes guidelinesA practice to diabetes guidelines
A practice to diabetes guidelines
 
1. Insuline and Anti diabetics
1. Insuline and Anti diabetics1. Insuline and Anti diabetics
1. Insuline and Anti diabetics
 
Pathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitusPathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitus
 
Diabetes and new anti diabetic drugs
Diabetes and new anti diabetic drugsDiabetes and new anti diabetic drugs
Diabetes and new anti diabetic drugs
 
Pharmacology Review & Perioperative Management of Diabetes
Pharmacology Review & Perioperative Management of Diabetes Pharmacology Review & Perioperative Management of Diabetes
Pharmacology Review & Perioperative Management of Diabetes
 
Dm 1 1
Dm 1 1Dm 1 1
Dm 1 1
 
DIABETES MELLITUS by dr aftab ahmed
DIABETES  MELLITUS by dr aftab ahmedDIABETES  MELLITUS by dr aftab ahmed
DIABETES MELLITUS by dr aftab ahmed
 
Diabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmedDiabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmed
 
diabetes mellitus.pptx
diabetes mellitus.pptxdiabetes mellitus.pptx
diabetes mellitus.pptx
 
Diabetes .pdf
Diabetes .pdfDiabetes .pdf
Diabetes .pdf
 
Diabetes drugs
Diabetes drugsDiabetes drugs
Diabetes drugs
 
Diabetes drugs
Diabetes drugsDiabetes drugs
Diabetes drugs
 
Diabetes nov2019 om alhamam (1)
Diabetes nov2019 om alhamam (1)Diabetes nov2019 om alhamam (1)
Diabetes nov2019 om alhamam (1)
 
DIABETES MELLITUS AND ANAESTHETIC IMPLICATIONS.pptx
DIABETES MELLITUS AND  ANAESTHETIC IMPLICATIONS.pptxDIABETES MELLITUS AND  ANAESTHETIC IMPLICATIONS.pptx
DIABETES MELLITUS AND ANAESTHETIC IMPLICATIONS.pptx
 
Diabetes and Glucose Metabolism
Diabetes and Glucose MetabolismDiabetes and Glucose Metabolism
Diabetes and Glucose Metabolism
 
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodDetermination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
 
Diabetes Mellitus patients in dental management
Diabetes Mellitus patients in dental managementDiabetes Mellitus patients in dental management
Diabetes Mellitus patients in dental management
 
The use of vildagliptin in patients with type 2 diabetes with renal impairment
The use of vildagliptin in patients with type 2 diabetes with renal impairmentThe use of vildagliptin in patients with type 2 diabetes with renal impairment
The use of vildagliptin in patients with type 2 diabetes with renal impairment
 

Mais de BALASUBRAMANIAM IYER

Risk stratification in post cardiac event cases
Risk stratification in post cardiac event casesRisk stratification in post cardiac event cases
Risk stratification in post cardiac event cases
BALASUBRAMANIAM IYER
 

Mais de BALASUBRAMANIAM IYER (20)

Project Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptxProject Status Report PowerPoint Template.pptx
Project Status Report PowerPoint Template.pptx
 
dyslipidemia6.ppt
dyslipidemia6.pptdyslipidemia6.ppt
dyslipidemia6.ppt
 
Cancer and immunology
Cancer and immunologyCancer and immunology
Cancer and immunology
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Infiximab
InfiximabInfiximab
Infiximab
 
Temisartan + chlorthalidone
Temisartan + chlorthalidoneTemisartan + chlorthalidone
Temisartan + chlorthalidone
 
Rrt
RrtRrt
Rrt
 
1
11
1
 
News2
News2News2
News2
 
Cilnidipine
CilnidipineCilnidipine
Cilnidipine
 
NGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarkerNGAL - Acute kidney injury biomarker
NGAL - Acute kidney injury biomarker
 
Are all arbs the same?
Are all arbs the same?Are all arbs the same?
Are all arbs the same?
 
Amh test
Amh testAmh test
Amh test
 
Karyotyping
KaryotypingKaryotyping
Karyotyping
 
Ca
CaCa
Ca
 
Amh
AmhAmh
Amh
 
Torch
TorchTorch
Torch
 
Triple maternal screen
Triple maternal screenTriple maternal screen
Triple maternal screen
 
Risk stratification in post cardiac event cases
Risk stratification in post cardiac event casesRisk stratification in post cardiac event cases
Risk stratification in post cardiac event cases
 

Último

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Último (20)

8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
 
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
 
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
 
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
 

Glimepiride

  • 1. Sulfonylureas in Type II DM Too Many Options, Too Little Clarity Dr. B. K. Iyer
  • 2. Diabetes – Status Today Diabetes Reaching Epidemic proportion Monitoring difficulties/complications Economic Implications Prevalence of CAD in the diabetic population, i.e., major abnormalities in ECG, angina, or myocardial infarction (MI) is 2­4 times than observed in nondiabetics. Prevalence of CCF to which CAD and hypertension contribute, is increased 3- to 4-fold. Uusitupa M, Siitonen O, Aro A, Pyörälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1985.
  • 3. Diabetes – Roadmap of Today What we know What we may not know What we need to know What we need to do after knowing The different sulfonylureas and relative comparisons Effects of sulfonylureas on cardiac risk factors Aspects of using sulfonylureas in diabetic patients The right approach to the choice of sulfonylureas Today’s review
  • 5. Normal Glucose Regulation insulin Fats Muscle insulin pancreatic islet  cells Glucose absorbed from intestine GLUCOSE ABSORPTION GLUCOSE PRODUCTION PERIPHERAL GLUCOSE UPTAKE INSULIN SECRETION
  • 6. OHAs Glucose Regulation Sulfonylureas Meglitinides Thiazolidinediones Metformin Thiazolidinediones  -Glucosidase Inhibitors Metformin Thiazolidinediones GLUCOSE ABSORPTION GLUCOSE PRODUCTION PERIPHERAL GLUCOSE UPTAKE INSULIN SECRETION
  • 7. Second Generation sulfonylureas – what is known? Yes No No Yes Active metabolites 24 10-24 24 16-24 Duration of action 400 -1000 2.4 1-2 Glimepiride 50 -100 1 10 Glipizide 30 4 80 Gliclazide 150 -400 3 5 Glyburide [Glibenclamide] Relative potency Plasma Peak Equiv. Dose [mg.] Sulfonylurea
  • 8. OHAs & Their Impact
  • 9. Sulfonylureas – Mechanism Of Action sulfonylureas bind to a subunit of the ß-cell ATP-activated K channel complex (termed the sulfonylurea receptor) This binding reduces the rate of outward flow [efflux] of K+ ions across cell membrane & leads to closure of the channel Kruszynska Y, Olefsky JM. J Invest Med. 1996; 44:413-428. This depolarizes the membrane and triggers opening of voltage-sensitive Ca++ channels, leading to rapid influx of Ca Increased intracellular Ca++ causes an alteration in the cytoskeleton, This stimulates translocation of insulin-containing secretory granules to the plasma membrane and exocytotic release of insulin.
  • 10. What May Be Unknown?
  • 11. Sulfonylureas – what may be Unknown? What is ischaemic preconditioning of myocardium? What is its significance ? Various studies have provided excellent evidence that in diabetic patients, Sulfonylureas bind also to cardiovascular K ATP channels in the myocardium, although less well than to ß-cell K ATP channels chronic inhibition of the K ATP channel in the beta cells of the pancreas with oral sulfonylureas abolishes ischaemic preconditioning of myocardium.
  • 12.
  • 13.
  • 14. Sulfonylureas – what may be Unknown? inhibit the opening of the potassium channel and promote closure interfere with the myocardial adaptive response Sulfonylureas could potentially disrupt this protective mechanism of ischaemic preconditioning by their presence and interaction with cardiovascular KATP. This could: This abolishing or opposing phenomenon might contribute to the increased cardiovascular mortality in sulfonylurea-treated diabetic patients
  • 15. Sulfonylureas – What Is Unknown? Despite their comparable actions on the pancreatic beta-cell KATP channel, all sulfonylureas are not similar because they strongly differ in their ability to interfere with vascular or cardiac KATP channels A useful pharmacological approach would be to identify  -cell-specific sulfonylureas to avoid adverse effects: on the cardiac myocyte, as well as vasculature Why? Thus, what must be done?
  • 16. How Does This Finding Advance Our Knowledge? Initiating / Continuance of long term oral pharmacotherapy Effects on fasting / Postprandial hyperglycaemia concern for benefits beyond the obvious concern for weight gain and hypo-glycaemia Expectations from sulfonylureas Rational Choice of Oral Antihyperglycaemic Agents, By Subhankar Chowdhury, Nilanjan Sengupta- JIMA, Vol. 100, No. 2, February 2002.
  • 17. What Needs to Be Known?
  • 18.
  • 19.
  • 20.
  • 21. Is there such a sulfonylurea? Yes! GLIMEPIRIDE
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48. What Needs to Be Done After Knowing? What Are the Lessons?
  • 49. The Future of Sulfonylureas: What Are the Lessons? Lesser Chances of weight gain / hypoglycaemia Decreased Insulinaemia Improvement In FBS, PPBG & Glycosylated Hb Lesser risks of atherosclerosis Increased Adiponectinaemia Extrapancreatic Effects Beta-Cell specific Preserves Myocardial preconditioning Action on both Phases of Insulin Secretion Rapid and Longer Duration Of Action
  • 50.
  • 51.

Notas do Editor

  1. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  2. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  3. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  4. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  5. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  6. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  7. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  8. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  9. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  10. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  11. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  12. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  13. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  14. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.
  15. Slide 2-4 Plasma Insulin After Oral Glucose: Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin levels are dependent upon obesity as well as diabetes. Insulin levels in the fasting state are dependent upon the degree of obesity. Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46: 1549-1557.